Capillary rarefaction and abnormal cardiovascular reactivity in hypertension

Journal of Hypertension

Volumn 21, Issue 12, 2003, Pages 2297-2303

  Ciuffetti, Giovanni ^a,b   Schillaci, Giuseppe ^a   Innocente, Salvatore ^a   Lombardini, Rita ^a   Pasqualini, Leonella ^a   Notaristefano, Salvatore ^a   Mannarino, Elmo ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

^b POLICLINICO MONTELUCE   (Italy)

Author keywords

Capillary rarefaction; Cardiovascular reactivity; Cycle ergometer; Essential hypertension; Rheology; Veno arteriolar reflex

Indexed keywords

PADGEM PROTEIN;

ADULT; ARTICLE; BICYCLE ERGOMETER; BLOOD PRESSURE; BLOOD RHEOLOGY; BLOOD VISCOSITY; CARDIOVASCULAR RESPONSE; CONTROLLED STUDY; ESSENTIAL HYPERTENSION; EXERCISE; HEART HEMODYNAMICS; HEART MUSCLE CAPILLARY; HEMATOCRIT; HUMAN; LASER DOPPLER FLOWMETRY; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MICROCIRCULATION; PRIORITY JOURNAL; VASOCONSTRICTION;

EID: 1442323628     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200312000-00018     Document Type: Article

References (33)

1. Sherwood A, Turner JR. A conceptual and methodologic overview of cardiovascular reactivity research. In: Turner JR, Sherwood A, Light KC (editors): Individual differences in cardiovascular response to stress. New York: Plenum Press; 1992, pp. 3-32.
2. Myers J, Prakash M, Froelicher V, Do D, Partington S, Atwood JE. Exercise capacity and mortality among men referred for exercise testing. N Engl J Med 2002; 346:793-801.
3. Matthews CE, Pate RR, Jackson KL, Ward DS, Mecera CA, Kohol HW, Blair SN. Exaggerated blood pressure response to dynamic exercise and risk of future hypertension. J Clin Epidemiol 1998; 51:29-35.
4. Goble MM, Schieken RM. Blood pressure response to exercise a marker for future hypertension? Am J Hypertens 1991; 4:6178-6208.
5. Miyai N, Arita M, Miyashita K, Morioka I, Shiraishi T, Nishio I. Blood pressure response to heart rate during exercise test and risk of future hypertension. Hypertension 2002; 39:761-766.
6. Mundal R, Kieldsen SE, Sandvik L, Erikssen G, Thaulow E, Erikssen J. Exercise blood pressure predicts mortality from myocardial infarction. Hypertension 1996; 27:324-329.
7. Wilson MF, Sung BH, Pincomb GA, Lovallo WR. Exaggerated pressure response to exercise in men at risk for systemic hypertension. Am J Cardiol 1990; 66:731-736.
8. Saitoh M, Miyakoda H, Kitamura H, Kinugawa T, Hisatome I, Kotake H, Mashiba H. Cardiovascular and sympathetic nervous response to dynamic exercise in patients with essential hypertension. Intern Med 1992; 31:1175-1178.
9. Ekstrand K, Nilsson JA, Lilja B, Bostrom PA, Arbolerius M. Markers for development of hypertension in commercial flight aviators. Aviat Space Environ Med 1991; 62:963-968.
10. Kavey RW, Kveselis DA, Gaun WE. Exaggerated blood pressure response to exercise in children with increased low-density lipoprotein cholesterol. Am Heart J 1997; 133:162-168.
11. Harper RN, Moore MA, Marr MC, Watts LE, Hutchins PM. Arteriolar rarefaction in the conjunctiva of human essential hypertensives. Microvasc Res 1978; 16:369-372.
12. Chen IH, Prewitt RL, Dowell RF. Microvascular rarefaction in spontaneously hypertensive rat cremaster muscle. Am J Physiol 1981; 241:H306-H310.
13. Antonios TFT, Singer DRJ, Markandu ND, Mortimer PS, MacGregor GA. Structural skin capillary rarefaction in essential hypertension. Hypertension 1999; 33:998-1001.
14. Levy BI, Ambrosio G, Pries AR, Strijker-Boudier HAJ. Microcirculation in hypertension. A new target for treatment? Circulation 2001; 104: 735-740.
15. Bagge U, Branemark PI. White blood cell rheology: an intravital study in man. In: Altura BM, Davis E, Harders H (editors): Advanced microcirculation. Basel: Karger; 1977, pp. 18-28.
16. Cerletti C, Evangelista V, De Gaetano G. P-selectin beta2-integrin cross-talk: a molecular mechanism for polymorphonuclear leukocyte recruitment at the site of vascular damage. Thromb Haemost 1999; 82:787-793.
17. Ciuffetti G, Pasqualini L, Pirro M, Lombardini R, De Sio M, Schillaci G, Mannarino E. Blood rheology in men with essential hypertension and capillary rarefaction. J Hum Hypertens 2002; 16:533-537.
18. Blann AD, Lip GY, Beevers DG, McCollum CN. Soluble P-selectin in atherosclerosis: a comparison with endothelial cell and platelet markers. Thromb Haemost 1997; 77:1077-1080.
19. Harkness J. The viscosity of human blood plasma; its measurement in health and disease. Biorheology 1971; 8:171-193.
20. International Committee for Standardization in Haematology (Expert Panel on Blood Rheology). Guidelines on selection of laboratory tests for monitoring the acute phase response. J Clin Pathol 1988; 41: 1203-1212.
21. Mikita J, Nash G, Dormandy J. A simple method of preparing white blood cells for filterability testing. Clin Hemorheol 1986; 6:635-639.
22. Lennie SE, Lowe GDO, Barbenel JC, Forbes CD, Foulds WS. Filterability of white blood cell subpopulations, separated by an improved method. Clin Hemorheol 1987; 7:811-816.
23. Nash GB, Jones JG, Mikita J, Christopher B, Dormandy JA. Effects of preparative procedures and of cell activation on flow of white cells through micropore filters. Br J Haematol 1988; 70:171-176.
24. Yosipovitch G, Schneiderman J, Van Dyk DJ, Chetrit A, Milo G, Boner G. Impairment of the postural veno-arteriolar response in young type-1 diabetic patients: a study by laser-Doppler flowmetry. Angiology 1996; 47:687-691.
25. Gianetti J, De Caterina M, De Cristofaro T, Ungaro B, Del Guercio R, De Caterina R. Intravenous prostaglandin E1 reduces soluble vascular cell adhesion molecule-1 in peripheral arterial obstructive disease. Am Heart J 2001; 142:733-739.
26. Nilsson GE, Tenland T, Oberg PA. Evaluation of a laser Doppler flowmeter for measurement of tissue blood flow. IEEE Trans Biomed Eng 1980; 27:597-604.
27. Noon JP, Walker BR, Webb DJ, Shore AC, Holton DW, Edwards HV, Watt GC. Impaired microvascular dilatation and capillary rarefaction in young adults with a predisposition to high blood pressure. J Clin Invest 1997; 99:1873-1879.
28. Ciuffetti G, Mercuri M, Mannarino E, Robinson MK, Lennie SE, Lowe G. Peripheral vascular disease. Rheologic variables during controlled ischemia. Circulation 1989; 80:348-352.
29. Lee AJ. Haemorheological, platelet and endothelial factors in essential hypertension. J Hum Hypertens 2002; 16:529-531.
30. Stuart J, George AJ, Davies AJ, Aukland A, Hurlow RA. Haematological stress syndrome in atherosclerosis. J Clin Pathol 1981; 34:464-467.
31. Lacombe C, Bucherer C, Lelievre JC, Perreaut E, Curty P, Vandewalle H. Hemorheologic effects following ergometric-controlled physical exercise [in French]. J Mal Vasc 1991; 16:79-82.
32. Peeters LLH, Buchan PC. Blood viscosity in perinatology. Rev Perinatal Med 1989; 6:53-89.
33. Prasad A, Dunnill GS, Mortimer PS, MacGregor GA. Capillary rarefaction in the forearm skin in essential hypertension. J Hypertens 1995; 13: 265-268.